Adults who are at least 18 years old who have a diagnosis of chronic plaque psoriasis with or without psoriatic arthritis, for at least 6 months, may qualify for this clinical research study and receive either an investigational injected treatment (active study drug), or a comparator medication.

Eligible participants must have stable moderate plaque psoriasis, with 10-15% of the body affected with the condition. 

Participants will have regular visits with an experienced research team. There is no cost to participate, and participants will be reimbursed for study-related expenses.

Please complete the form below to see if you are eligible for this trial.

If you have any questions/queries regarding this trial please email | [email protected]